Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a devastating and fatal chronic lung disease. While current pharmacotherapies have improved patient quality of life, PAH drugs suffer from limitations in the form of short-term pharmacokinetics, instability, and poor organ specificity. Traditionally, nanotech...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Front Physiol
मुख्य लेखकों: Segura-Ibarra, Victor, Wu, Suhong, Hassan, Nida, Moran-Guerrero, Jose A., Ferrari, Mauro, Guha, Ashrith, Karmouty-Quintana, Harry, Blanco, Elvin
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Frontiers Media S.A. 2018
विषय:
Physiology
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6055049/
https://ncbi.nlm.nih.gov/pubmed/30061840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2018.00890
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन